Aligos Therapeutics, Inc. - Common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $2.8 | $0.7 | $1 | $0.3 | $1.3 | $1.1 | $0.7 | |
| −$1.5 | −$23 | −$32 | −$16 | $43 | −$19 | $5.1 | −$35 | |
| −$0.14 | −$2.21 | −$3.04 | −$1.53 | −$2.11 | −$3.07 | $0.81 | −$5.58 | |
| 10 | 10 | 10 | 10 | 8.7 | 6.3 | 6.3 | 6.2 |
Trend